STAT3 mediates angiogenesis in laryngeal cancer, and inhibition of the JAK-2/Stat-3 signaling pathway significantly inhibits invasion in vitro and angiogenesis of laryngeal cancer. Here, JAK2 is linked to laryngeal carcinoma.